Research and Markets: Study this Comprehensive Analytical Review of All Aspects of the Oncology Field
Research and Markets (researchandmarkets. com/reports/c14937) has announced the addition of Future Oncology to their offering.
Research and Markets (PRWEB) April 5, 2005
Future Oncology is a comprehensive, analytical review of all aspects of the oncology field for executives, researchers, and market analysts in the pharmaceutical, biotechnology, financial, hospital and other health care related sectors. It provides comprehensive, up-to-date analysis of scientific, technological, clinical and commercial developments in oncology.
To date, Future Oncology, has presented comprehensive information on all major malignancies, covering over 1,000 oncology drugs in development (by developer/affiliate, mechanism of action, indication and status), as well as numerous other related products, and profiled hundreds of developers worldwide.
For every cancer indication, the publication presents extensive global epidemiology (incidence and mortality), and USA epidemiology by gender, age, disease stage and survival by stage. In addition, descriptions of targets with utility as diagnostic, prognostic or therapeutic applications, in vitro and in vivo diagnostics in development or on the market, and protocols/results from monotherapy and combination trials of approved agents and those in development, are presented as well estimated treatment costs.
Future Oncology is published as 12 issues (several double issues) per subscription period, with a free index listing companies/institutions and subjects covered.
Example of some topics covered in this publication include:
-Pancreatic Cancer
-Angiogenesis Inhibitors/Antimetastatic Agents And Targeted
Delivery/Gene Transfer Approaches
-Endothelial Monocyte-activating Protein II (IMAP-II)
-Vascular Endothelial Growth Factor (VEGF) Inhibitors
-Urokinase Plasminogen Activator (uPA) System Inhibitors
-Other Antiangiogenesis Agents
-Targeted Drug Delivery
-Targeted Toxins
-Radioimmunoconjugates
-Targeted Cytotoxics
-Gene Transfer
-Oncolytic Viruses
For more information visit http://www. researchandmarkets. com/reports/c14937 (http://www. researchandmarkets. com/reports/c14937)
Laura Wood
Senior Manager
Research and Markets
Press@researchandmarkets. com
Fax: +353 1 4100 980
###
